BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Anchor Therapeutics 

67 Rogers Street

Cambridge  Massachusetts  02142  U.S.A.
Phone: 617-715-1999 Fax: 617-715-7906


SEARCH JOBS


Industry
Biotechnology






 Company News
Anchor Therapeutics Enters Into Collaborative Research Agreement With Kyowa Hakko Kirin for its Pepducin Technology 7/31/2012 9:51:28 AM    More...
Anchor Therapeutics Achieves Milestone in GPCR Collaboration 1/10/2011 11:45:58 AM    More...
Anchor Therapeutics Announces Collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., Potential $480 Million in Milestones 9/9/2010 6:33:31 AM    More...
Anchor Therapeutics Nabs $10M for New Class of Peptide Drugs Against Hard Targets 8/20/2010 6:58:03 AM    More...
Anchor Therapeutics Adds Global Experts to Board of Directors and Scientific Advisory Board 7/21/2010 12:41:38 PM    More...
Ascent Therapeutics Changes Name to Anchor Therapeutics 3/30/2010 8:51:30 AM    More...
Ascent Therapeutics Achieves Preclinical in vivo Proof-of-Principle with Novel Pepducin(TM) GPCR Modulator Platform and Strengthens Senior Management Team 9/11/2009 9:52:08 AM    More...
Ascent Therapeutics Appoints Industry Leaders to Senior Management Team 6/3/2009 8:54:11 AM    More...
Massachusetts Biotechnology Council, Inc. Release: 19 Biotech Companies Selected to Present at 10th Annual MassBio Investors Forum 12/2/2008 12:29:28 PM    More...
Ascent Therapeutics Debuts with the Appointment of CEO; $19 Million Series A 11/18/2008 8:28:28 AM    More...

//-->